思拓凡 Cytiva Sefia S2000 细胞处理系统上海善福电子科技有限公司

Sefia Cytiva. CT300.1 Sefia Kit Cytiva The Sefia™ cell therapy manufacturing platform is made up of two digitally integrated and functionally closed systems that automate key manufacturing steps In order to operate the Sefia Select module in the way it is intended: • The user must have a general understanding of cell processing, and knowledge

Cytiva、イノベーションと自動化技術による次世代の細胞治療薬製造プラットフォーム「Sefia™」を「第8回バイオ医薬 EXPO」で披露
Cytiva、イノベーションと自動化技術による次世代の細胞治療薬製造プラットフォーム「Sefia™」を「第8回バイオ医薬 EXPO」で披露 from bio.nikkeibp.co.jp

The Sefia™ cell therapy manufacturing platform is made up of two digitally integrated and functionally closed systems that automate key manufacturing steps An introduction of the new, end-to-end solution from Cytiva to manufacture autologous CAR T therapies at commercial scale

Cytiva、イノベーションと自動化技術による次世代の細胞治療薬製造プラットフォーム「Sefia™」を「第8回バイオ医薬 EXPO」で披露

An introduction of the new, end-to-end solution from Cytiva to manufacture autologous CAR T therapies at commercial scale The Sefia S-2000 cell processing instrument is also referred to as the "Sefia instru-ment" throughout this manual An introduction of the new, end-to-end solution from Cytiva to manufacture autologous CAR T therapies at commercial scale

CT300.1 Sefia Kit Cytiva. Overview of Sefia Select system, combining hardware, application software and kits to automate cell isolation, harvest and formulation for cell therapy manufacturing Overview of Sefia Select single use consumables to functionally close cell isolation, harvest and formulation for cell therapy manufacturing

Cytiva opens Swiss manufacturing facility and Center of Excellence for. Implementation of the Sefia™ platform enables us to increase efficiencies and produce CAR T cell therapies at a global scale." WARNING The single-use kits are sterilized with Ethylene Oxide (EtO) and anaphylactic reactions can occur in hypersensitive people.